ROYAL BANK OF CANADA - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 38 filers reported holding OCUPHIRE PHARMA INC in Q2 2021. The put-call ratio across all filers is 4.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$52,000
-44.1%
15,405
-28.0%
0.00%
Q2 2023$93,00021,405
+428000.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$050.0%0.00%
Q3 2022$050.0%0.00%
Q2 2022$050.0%0.00%
Q1 2022$050.0%0.00%
Q4 2021$050.0%0.00%
Q3 2021$050.0%0.00%
Q2 2021$050.0%0.00%
Q1 2021$050.0%0.00%
Q4 2020$050.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders